These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 22402432

  • 1. What Is the best treatment for HIV-associated multicentric Castleman disease?
    Bower M, Dalla Pria A.
    Clin Adv Hematol Oncol; 2012 Mar; 10(3):207-9. PubMed ID: 22402432
    [No Abstract] [Full Text] [Related]

  • 2. Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.
    Peker D, Martinez AE, Schwartz MA, Cusnir M.
    Clin Adv Hematol Oncol; 2012 Mar; 10(3):204-6. PubMed ID: 22402431
    [No Abstract] [Full Text] [Related]

  • 3. [Castleman's disease, HIV and rituximab].
    Valencia ME, López V, Corcuera MT, Del Val D.
    Rev Clin Esp; 2012 Feb; 212(2):118-9. PubMed ID: 21924712
    [No Abstract] [Full Text] [Related]

  • 4. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease.
    Neuville S, Agbalika F, Rabian C, Brière J, Molina JM.
    Am J Hematol; 2005 Aug; 79(4):337-9. PubMed ID: 16044438
    [Abstract] [Full Text] [Related]

  • 5. Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.
    Stary G, Kohrgruber N, Herneth AM, Gaiger A, Stingl G, Rieger A.
    AIDS; 2008 Jun 19; 22(10):1232-4. PubMed ID: 18525273
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Autoimmune hemolytic anemia with warm-reactive immunoglobulin M antibody in multicentric Castleman disease.
    Tajima K, Yamamoto H, Suzuki I, Kato Y, Hatano K, Takahashi S, Sato M, Kato T.
    Ann Hematol; 2013 Jun 19; 92(6):849-51. PubMed ID: 23180435
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody.
    Gholam D, Vantelon JM, Al-Jijakli A, Bourhis JH.
    Ann Hematol; 2003 Dec 19; 82(12):766-8. PubMed ID: 12898190
    [Abstract] [Full Text] [Related]

  • 12. Multicentric Castleman disease complicated by tumor lysis syndrome after systemic chemotherapy.
    Lee JH, Kwon KA, Lee S, Oh SY, Kwon HC, Han JY, Hong SH, Kim SH.
    Leuk Res; 2010 Jan 19; 34(1):e42-5. PubMed ID: 19747731
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Siltuximab (Sylvant) for treatment of multicentric castleman's disease.
    Med Lett Drugs Ther; 2015 Jan 05; 57(1459):e8. PubMed ID: 25555075
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena.
    Ocio EM, Sanchez-Guijo FM, Diez-Campelo M, Castilla C, Blanco OJ, Caballero D, San Miguel JF.
    Am J Hematol; 2005 Apr 05; 78(4):302-5. PubMed ID: 15795923
    [Abstract] [Full Text] [Related]

  • 16. Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease.
    van Aalderen MC, Brinkman K, van den Berk GE, Terpstra WE.
    Neth J Med; 2010 Feb 05; 68(2):87-90. PubMed ID: 20167961
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multicentric Castleman disease presenting with fever.
    Smith C, Lee-Miller C, Dishop MK, Cost C, Wang M, Asturias EJ.
    J Pediatr; 2014 Dec 05; 165(6):1261-5. PubMed ID: 25282064
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.